Charles Deignan
Director of Finance/CFO chez CLEARSIDE BIOMEDICAL, INC.
Fortune : 588 533 $ au 31/03/2024
Profil
Charles A.
Deignan is currently the Chief Financial Officer at Clearside Biomedical, Inc. He previously worked as a Finance Manager at Schering-Plough Corp.
from 1990 to 1994, a Division Controller at AAIPharma, Inc., the President, Chief Financial Officer & Secretary at AtheroGenics, Inc. in 2009, and the Vice President-Finance & Administration at Salutria Pharmaceuticals, Inc. from 2009 to 2011.
Deignan received his undergraduate degree from Boston University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/01/2024 | 384 662 ( 0,51% ) | 588 533 $ | 31/03/2024 |
Postes actifs de Charles Deignan
| Sociétés | Poste | Début |
|---|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Director of Finance/CFO | 01/01/2012 |
Anciens postes connus de Charles Deignan
| Sociétés | Poste | Fin |
|---|---|---|
Salutria Pharmaceuticals, Inc.
 Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Director of Finance/CFO | 01/12/2011 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | President | 14/07/2009 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Director of Finance/CFO | 01/01/1994 |
AAIPharma, Inc.
 AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Corporate Officer/Principal | - |
Formation de Charles Deignan
| Boston University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
AAIPharma, Inc.
AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Commercial Services |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Salutria Pharmaceuticals, Inc.
Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Retail Trade |
